glucose, (beta-d)-isomer has been researched along with Hypertriglyceridemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dvorakova, I; Haluzik, M; Huttl, M; Kasperova, BJ; Kratochvilova, H; Kuzma, M; Malinska, H; Markova, I; Melcova, M; Mraz, M; Oliyarnyk, O; Pelantova, H; Rosolova, K; Skop, V; Stemberkova-Hubackova, S; Svoboda, P; Trnovska, J | 1 |
| Gustafson, KM; Kellon, EM | 1 |
| Abdalla, O; Dessouki, A; Kilany, O; Sasaki, K; Sayed, N; Shimoda, M; Yoshida, T | 1 |
| Imai, Y; Kaneto, M; Nakatou, T; Senoo, M; Shimomura, Y; Teshigawara, S; Tone, A; Watanabe, S | 1 |
| Dobbins, R; Dorey, DJ; Kler, L; Lorimer, JD; O'Connor-Semmes, R; Sykes, AP; Walker, S; Wilkison, WO | 1 |
| Li, D; Li, G; Ling, W; Wang, D; Wei, X; Xia, M; Xiao, Y; Yang, Y; Zhu, Y | 1 |
| Han, XH; Hoang, MH; Hwang, BY; Jia, Y; Jun, HJ; Lee, DH; Lee, HJ; Lee, JH; Lee, SJ | 1 |
| Chaen, H; Kibata, M; Kubota, M; Mishima, Y; Mitsuzumi, H; Miwa, Y; Okada, K; Sunayama, T; Yamada, M | 1 |
1 trial(s) available for glucose, (beta-d)-isomer and Hypertriglyceridemia
| Article | Year |
|---|---|
Randomized trial showing efficacy and safety of twice-daily remogliflozin etabonate for the treatment of type 2 diabetes.
Topics: Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Glucosides; Glycated Hemoglobin; Humans; Hyperglycemia; Hypertriglyceridemia; Hypoglycemia; Hypoglycemic Agents; Intention to Treat Analysis; Membrane Transport Modulators; Middle Aged; Patient Dropouts; Pioglitazone; Prodrugs; Pyrazoles; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidinediones; Weight Loss | 2015 |
7 other study(ies) available for glucose, (beta-d)-isomer and Hypertriglyceridemia
| Article | Year |
|---|---|
Complex Positive Effects of SGLT-2 Inhibitor Empagliflozin in the Liver, Kidney and Adipose Tissue of Hereditary Hypertriglyceridemic Rats: Possible Contribution of Attenuation of Cell Senescence and Oxidative Stress.
Topics: 3T3-L1 Cells; Adipose Tissue; Administration, Oral; Animals; Benzhydryl Compounds; Cell Survival; Cellular Senescence; Disease Models, Animal; Down-Regulation; Dyslipidemias; Gluconeogenesis; Glucosides; Hep G2 Cells; Humans; Hypertriglyceridemia; Hypoglycemic Agents; Insulin Resistance; Kidney; Lipogenesis; Liver; Male; Mice; Oxidative Stress; Rats; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; Up-Regulation; Weight Gain | 2021 |
Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors.
Topics: Animals; Canagliflozin; Diabetes Mellitus, Type 2; Glucose; Glucosides; Horse Diseases; Horses; Hyperinsulinism; Hyperlipidemias; Hypertriglyceridemia; Hypoglycemic Agents; Male; Metformin; Sodium-Glucose Transporter 2 Inhibitors | 2023 |
Effect of dapagliflozin alone and in combination with insulin in a rat model of type 1 diabetes.
Topics: Animals; Antioxidants; Benzhydryl Compounds; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Glucosides; Hypercholesterolemia; Hyperglycemia; Hypertriglyceridemia; Hypoglycemic Agents; Insulin; Male; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Marked Hypertriglyceridemia in a Patient with type 2 Diabetes Receiving SGLT2 Inhibitors.
Topics: Adult; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Diet, Carbohydrate-Restricted; Glucosides; Humans; Hypertriglyceridemia; Male; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Cyanidin-3-O-β-glucoside improves obesity and triglyceride metabolism in KK-Ay mice by regulating lipoprotein lipase activity.
Topics: AMP-Activated Protein Kinases; Animals; Anthocyanins; Cells, Cultured; Dietary Supplements; Female; Functional Food; Gene Expression Regulation, Enzymologic; Glucosides; Hypertriglyceridemia; Intra-Abdominal Fat; Lipoprotein Lipase; Liver; Mice; Muscle, Skeletal; Obesity; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; RNA, Messenger; Triglycerides | 2011 |
Catalposide is a natural agonistic ligand of peroxisome proliferator-activated receptor-α.
Topics: Fatty Acids; Fluorescence Resonance Energy Transfer; Genes, Reporter; Glucosides; Hep G2 Cells; Hepatocytes; Humans; Hypertriglyceridemia; Ligands; Lipid Metabolism; Lipids; PPAR alpha | 2012 |
Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality.
Topics: Adult; Alanine Transaminase; Apolipoproteins; Aspartate Aminotransferases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; gamma-Glutamyltransferase; Glucosides; Hesperidin; Humans; Hypertriglyceridemia; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Particle Size; Phenotype; Triglycerides | 2005 |